0000874015-13-000045.txt : 20130321 0000874015-13-000045.hdr.sgml : 20130321 20130321202501 ACCESSION NUMBER: 0000874015-13-000045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130320 FILED AS OF DATE: 20130321 DATE AS OF CHANGE: 20130321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEIN JOSEPH III CENTRAL INDEX KEY: 0001206369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 13708949 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-03-20 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001206369 KLEIN JOSEPH III C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 Common Stock 2013-03-20 2013-03-20 4 M 0 2500 16.32 A 2500 I By Son Common Stock 2013-03-20 2013-03-20 4 S 0 2500 18.00 D 0 I By Son Common Stock 2013-03-20 2013-03-20 4 M 0 1250 9.22 A 1250 I By Son Common Stock 2013-03-20 2013-03-20 4 S 0 1250 18.00 D 0 I By Son Common Stock 2013-03-20 2013-03-20 4 M 0 174 5.93 A 174 I By Son Common Stock 2013-03-20 2013-03-20 4 S 0 174 18.00 D 0 I By Son Common Stock 8000 D Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 9/7/2012. Report 2 of 2 /s/B. Lynne Parshall, Attorney-in-Fact 2013-03-21